Amycretin Side Effects: What You Need to Know

Amycretin is one of the most promising new weight loss medications expected to launch in the UK market. Developed by Novo Nordisk, Amycretin is a GLP-1 and amylin receptor agonist that has shown significant results in reducing body weight in clinical trials. While the benefits are exciting, understanding the potential side effects is essential for anyone considering treatment.

Common Side Effects of Amycretin

Amycretin has undergone extensive clinical testing, and results confirm that it is generally well-tolerated. The safety profile observed in trials closely mirrors that of other GLP-1 receptor agonists commonly used for weight management. Most side effects were mild to moderate and gastrointestinal in nature, with frequencies depending on individual response and dosage levels. Below is a comprehensive breakdown of the most commonly reported side effects during the clinical trials of Amycretin.

Experiencing side effects is common with GLP‑1 drugs, but if you’re comparing Amycretin’s side‑effect profile against other treatments like Wegovy, take a look at our full breakdown here: Amycretin vs Wegovy Weight Loss Comparison.

Gastrointestinal Issues

• Nausea: 27%
  
• Diarrhoea: 20%
  
• Vomiting: 11%
  
• Constipation: Frequency not specified
  

Other Reported Adverse Reactions

• Fatigue: 23%
  

Headache: 16%

Comparison with Placebo

Side effects reported by at least 2% of patients treated with Amycretin and occurring at a rate greater than placebo included:

• Nausea: 11% vs. placebo
  
• Fatigue: 9% vs. placebo
  
• Diarrhoea: 8% vs. placebo
  
• Headache: 6% vs. placebo
  
• Vomiting: 5% vs. placebo
  

Side Effect Profile Similarity

The side effect profile of Amycretin is consistent with that of other GLP-1 drugs including Wegovy. Patients may experience:

• Nausea
  
• Vomiting
  
• Diarrhoea
  

These effects are particularly noted when the dosage is increased too rapidly. It is important for patients to be aware of these potential side effects and to consult healthcare providers for management strategies.

Why Side Effects Occur

Amycretin acts on the GLP-1 and amylin receptors, both of which regulate appetite, satiety, and gastric emptying. As these hormones influence digestion and gut motility, side effects like nausea or diarrhoea are common, especially during the initial weeks of treatment.

The Bottom Line

Amycretin offers a promising new approach to weight loss with a manageable side effect profile. Understanding what to expect and how to manage side effects can improve your experience with the medication.

If you’re considering Amycretin in the near future, speak to a medical professional to assess whether it’s the right treatment for your needs.

Looking to start your weight loss journey?

When Amycretin becomes available in the UK, MedCare Health Clinic will provide private prescriptions, consultation, and full support for patients seeking innovative GLP-1 treatment options.Stay informed by visiting medcare-healthclinic.com or joining our early interest list today.